[1] Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation [J]. Nature reviews Immunology, 2015, 15(1)∶30-44 [2] Pan S, Lei L, Chen S, et al. Rosiglitazone impedes Porphyromonas gingivalis-accelerated atherosclerosis by downregulating the TLR/NF-kappaB signaling pathway in atherosclerotic mice [J]. International immunopharmacology, 2014, 23(2)∶701-708 [3] Gitlin JM, Loftin CD. Cyclooxygenase-2 inhibition increases lipopolysaccharide-induced atherosclerosis in mice [J]. Cardiovascular research, 2009, 81(2)∶400-407 [4] Lin G, Shi X, Chen S, et al. Effects of micro-amounts of Porphyromonas gingivalis lipopolysaccharide on rabbit inflammatory immune response and development of atherosclerosis [J]. Journal of periodontal research, 2015, 50(3)∶356-362 [5] Semple F, Webb S, Li HN, et al. Human beta-defensin 3 has immunosuppressive activity in vitro and in vivo [J]. European journal of immunology, 2010, 40(4)∶1073-1078 [6] 洪菲菲, 雷浪, 潘盛波, 等. 牙龈卟啉单胞菌脂多糖对髓系细胞触发受体的激活作用 [J].口腔医学研究,2015,31(3)∶213-216 [7] Chen S, Lin G, Lei L, et al. Hyperlipidemia modifies innate immune responses to lipopolysaccharide via the TLR-NF-kappaB signaling pathway [J]. Inflammation, 2013, 36(4)∶968-976 [8] Curtis MA, Percival RS, Devine D, et al. Temperature-dependent modulation of Porphyromonas gingivalis lipid A structure and interaction with the innate host defenses [J]. Infection and immunity, 2011, 79(3)∶1187-1193 [9] Lei L, Li H, Yan F, et al. Hyperlipidemia impaired innate immune response to periodontal pathogen porphyromonas gingivalis in apolipoprotein E knockout mice [J]. PloS one, 2013, 8(8)∶e71849 [10] Harder J, Bartels J, Christophers E, et al. Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic [J]. The Journal of biological chemistry, 2001, 276(8)∶5707-5713 [11] Kohlgraf KG, Ackermann A, Lu X, et al. Defensins attenuate cytokine responses yet enhance antibody responses to Porphyromonas gingivalis adhesins in mice [J]. Future microbiology, 2010, 5(1)∶115-125 [12] Lee SH, Jun HK, Lee HR, et al. Antibacterial and lipopolysaccharide (LPS)-neutralising activity of human cationic antimicrobial peptides against periodontopathogens [J]. International journal of antimicrobial agents, 2010, 35(2)∶138-145 [13] Semple F, MacPherson H, Webb S, et al. Human beta-defensin 3 affects the activity of pro-inflammatory pathways associated with MyD88 and TRIF [J]. European journal of immunology, 2011, 41(11)∶3291-3300 [14] Holden JA, Attard TJ, Laughton KM, et al. Porphyromonas gingivalis lipopolysaccharide weakly activates M1 and M2 polarized mouse macrophages but induces inflammatory cytokines [J]. Infection and immunity, 2014, 82(10)∶4190-4203 [15] 刘译聪,武洲,于维先,等.巴西天然蜂胶对牙龈卟啉单胞菌激活的巨噬细胞极化的调控及机制探讨[J].口腔医学研究,2013,29(12)∶1107-1110+1113 |